Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $0.13.

  • Fortress Biotech's EPS (Basic) rose 11710.53% to $0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.11, marking a year-over-year increase of 9640.52%. This contributed to the annual value of -$2.69 for FY2024, which is 6825.21% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's EPS (Basic) is $0.13, which was up 11710.53% from $0.5 recorded in Q2 2025.
  • Fortress Biotech's 5-year EPS (Basic) high stood at $0.5 for Q2 2025, and its period low was -$4.82 during Q4 2022.
  • For the 5-year period, Fortress Biotech's EPS (Basic) averaged around -$1.14, with its median value being -$0.48 (2025).
  • As far as peak fluctuations go, Fortress Biotech's EPS (Basic) plummeted by 182777.78% in 2023, and later surged by 16849.32% in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's EPS (Basic) stood at -$0.38 in 2021, then tumbled by 1168.42% to -$4.82 in 2022, then soared by 89.0% to -$0.53 in 2023, then increased by 12.38% to -$0.46 in 2024, then soared by 127.99% to $0.13 in 2025.
  • Its last three reported values are $0.13 in Q3 2025, $0.5 for Q2 2025, and -$0.48 during Q1 2025.